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Abstract
Background: Damage to nerve cells and axons leading to neurodegeneration is a characteristic feature of many
neurological diseases. The degree of genetic influence on susceptibility to axotomy-induced neuronal death has so far been
unknown. We have examined two gene regions, Vra1 and Vra2, previously linked to nerve cell loss after ventral root avulsion
in a rat F2 intercross between the DA and PVG inbred rat strains.
Methodology/Principal Findings: In this study, we use two generations (G8 and G10 cohorts) of an advanced intercross line
between DA and PVG
av1 to reproduce linkage to Vra1 and to fine-map this region. By isolating the effect from Vra1 in
congenic strains, we demonstrate that Vra1 significantly regulates the loss of motoneurons after avulsion. The regulatory
effect mediated by Vra1 thus resides in a congenic fragment of 9 megabases. Furthermore, we have used the advanced
intercross lines to give more support to Vra2, originally detected as a suggestive QTL.
Conclusions/Significance: The results demonstrated here show that naturally occurring allelic variations affect susceptibility
to axotomy-induced nerve cell death. Vra1 and Vra2 represent the first quantitative trait loci regulating this phenotype that
are characterized and fine mapped in an advanced intercross line. In addition, congenic strains provide experimental
evidence for the Vra1 effect on the extent of injury-induced neurodegeneration. Identification of the underlying genetic
variations will increase our understanding of the regulation and mechanisms of neurodegeneration.
Citation: Swanberg M, Harnesk K, Stro ¨m M, Diez M, Lidman O, et al. (2009) Fine Mapping of Gene Regions Regulating Neurodegeneration. PLoS ONE 4(6): e5906.
doi:10.1371/journal.pone.0005906
Editor: Rafael Linden, Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Biofı ´sica da UFRJ, Brazil
Received March 19, 2009; Accepted May 19, 2009; Published June 15, 2009
Copyright:  2009 Swanberg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and EURATools, LSHG-CT-
2005019015, the Swedish Research Council, Wadsworth Foundation, the Swedish Society for Medical Research, the Swedish Brain Foundation, the Nils and Bibbi
Jenssens Foundation, the Montel Williams MS Foundation, the GV80 Foundation, the Soderberg Foundation, and the Swedish Association of Persons with
Neurological Disabilities. The funders had no role in study design, data collection or analysis, manuscript preparation or decision to publish.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: fredrik.piehl@ki.se
. These authors contributed equally to the work.
Introduction
Many diseases of the central nervous system (CNS) are
characterized by neuron/axon damage leading to neurodegener-
ation. The complex aetiology of neurodegenerative disorders
includes a genetic predisposition. Unlike monogenic traits, most
genes that are involved in common complex diseases are likely to
be evolutionarily conserved, vary between diseased individuals,
and only modestly affect risk. This makes disease predisposing
genes difficult to identify, and so far only a small number of genes
regulating complex traits have been characterized. One strategy is
to genetically dissect disease phenotypes in intercrosses of inbred
rodent strains, which are susceptible or resistant in relevant disease
models [1,2,3]. Genome wide linkage analysis can be performed in
an F2 intercross between two inbred strains. All F2 individuals are
related but genetically unique, which enables positioning of
quantitative trait loci (QTLs). Further intercrossing generates an
advanced intercross line (AIL), which increases the genetic
resolution and allows for fine mapping of QTLs identified in a
genome wide linkage analysis. This has proven fruitful for
resolving the genetic contribution to complex traits such as
autoimmune neuroinflammation, reviewed in [4]. Apart from
identifying candidate genes that can be tested in clinical materials,
this type of experimental genetic dissection can unravel informa-
tion about disease-related molecular pathways [3,5,6].
We have set out to characterize the genetic influence on
neurodegeneration in a simple and reproducible mechanical nerve
lesion model; ventral root avulsion (VRA) in the rat [7,8,9]. VRA
results in a very proximal axotomy of motor axons at the boundary
of the central and peripheral nervous systems, with a subsequent
substantial loss of axotomized cells during the second and third
post-operative weeks. Lesioned motoneurons deprived of physical
contact with peripheral nerve tissue, thus, degenerate in a similar
fashion as many other CNS nerve cell populations [10]. This
makes VRA a useful model for studying neurodegeneration in the
CNS. Previously we reported results from a whole genome scan of
an F2 intercross between the DA and PVG (RT1C) rat strains,
which revealed four QTLs regulating different aspects of the VRA
response. Vra1 and Vra2 were linked to neurodegeneration, Vra3
displayed suggestive linkage to T cell infiltration and Vra4 was
linked to differential expression of MHC class II [11]. Fine
mapping of Vra4 in an AIL between DA and PVG
av1 rats,
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inbred strains, resulted in the identification of the underlying gene,
Mhc2ta, encoding the MHC class II transactivator. This gene was
also found to be associated to human inflammatory disorders [5].
In this study we set out to reproduce and fine map the strongest
QTL, Vra1, with regard to neurodegeneration by studying two
generations of the DA and PVG
av1 AIL and Vra1 congenic
animals. This refines a 9 megabases (Mb) large fragment that
significantly regulates motoneuron loss after VRA. Further, we use
the experimental setup of the AIL to give more support to and fine
map the second suggestive QTL, Vra2. Taken together, our data
demonstrate a substantial genetic regulation of nerve-injury
induced neurodegeneration and provide information about two
candidate gene regions, one of them with high genomic resolution.
Results
Fine mapping of Vra1 using an advanced intercross line
Two generations, the G8 and G10 of a DAxPVG
av1 AIL were
used for finemapping of Vra1 and Vra2. The G8 and G10 cohorts
consisted of 126 and 186 males, respectively. Thirteen and ten
animals in the G8 and G10 cohorts, respectively, were excluded
from the analysis due to incomplete lesion. The success rate for
genotyping was 97.9% in G8 and 97.6% in G10. Nerve cell counts
in the parental control strain demonstrated 47% and 38% mean
nerve cell survival in PVG
av1 and DA strains, respectively,
corresponding to a 23% relative increase in survival in PVG
av1
compared to DA. The mean survival in the G8 and G10 cohorts
14 days after VRA was 40% and 41%, respectively (Fig 1A). A
cresyl violet stained section, demonstrating neuron loss in the
ventral cord in the DA rat 21 days after VRA, is shown in Fig 1B.
Vra1 was covered by 19 markers spanning 54 Mb in the G8
cohort and 13 markers spanning 40 Mb in the G10 cohort. Vra1
was linked to the degree of motoneuron loss in both AIL cohorts,
thus replicating the linkage originally described in the F2
intercross. The logarithm of odds (LOD) scores were 3.46 and
3.19 for the G8 and G10 cohorts, respectively, using the multiple
imputation method (Fig 2A). This exceeds the threshold levels
obtained by calculating family residual effects, which were 1.19
and 1.39, and the 95% experiment-wise threshold level of 2.79
and 2.60 in G8 and G10 data sets, respectively, as generated by
permutations. Furthermore, a combined cross analysis based on 12
common markers in the G8 and G10 cohorts resulted in
strengthened evidence for linkage to neurodegeneration for Vra1,
as the LOD score rose to 5.9 using marker regression analysis
(Fig 2A). The mean cell survival of animals that were homozygous
(DA/DA or PVG
av1/PVG
av1) or heterozygous (DA/PVG
av1)a t
the max marker D8Rat205 differ significantly (Fig 2B). In
addition, the AIL experiments narrowed the candidate region
from 55 Mb in the F2 cross to roughly 16 Mb (Fig 2C). Data on
flanking and max markers, genomic position and confidence
intervals for Vra1 in the G8, G10 and combined linkage peaks are
presented in Table 1.
Reproduction of Vra2
A second gene region, Vra2 on chromosome 5, was identified as
a QTL displaying suggestive linkage to nerve cell death in the
original F2 intercross [11]. To cover the Vra2 F2 linkage peak, 13
markers spanning 40 Mb were used in the G8 cohort, and 12
markers spanning 34 Mb were used in the G10 cohort. While no
evidence of linkage to the Vra2 region was found in G8, linkage
with a LOD score of 2.39 for the max marker (D5Rat190) was
found in the G10 cohort (Fig 3A). This value is slightly lower than
that of the F2 population (Fig 3C), but exceeds the family effect
level of 1.35 and the 90% experiment-wise threshold level of 2.29.
The linkage to Vra2 in the G10 cohort thereby reach the same
level of significance as in the original F2 cross. The average cell
survival of animals carrying DA or PVG
av1 alleles at D5Rat190 is
illustrated in Fig 3B. Combined analysis of G8 and G10 for Vra2
did not increase linkage and only reached significance when cross
was used as covariate, showing that the effect is cross specific for
the G10 cohort.
Vra1-Vra2 interaction analysis
A two dimensional scan in the G10 cohort revealed a strong
additive effect of Vra1 and Vra2, with a LOD score of 6.39 using
the imputation method. The maximum additive LOD score was
detected with the markers D5Rat190 and D8Rat75 (see Table 1).
In order to check whether the two analyzed QTLs separately
contributed to the LOD score, the multiple QTL model was fitted
Figure 1. Motoneuron survival after ventral root avulsion (VRA). (A) Distribution of nerve cell survival in parental controls and AIL cohorts,
sampled 14 days after VRA. Horizontal lines indicate mean survival rate for DA (0.38), PVG
av1 (0.47), G8 (0.40), G10 (0.41). (B) Cresyl violet counter
stained section demonstrating loss of motoneurons on the side of the lesion (IL) in DA rat 21 days after VRA (IL=ipsilateral), scale bar=0.5 mm.
doi:10.1371/journal.pone.0005906.g001
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or Vra2 showed a highly significant reduction of the additive LOD
(p,0.001 with F statistics). In addition, the interaction plot shows
an increased nerve cell loss in carriers of DA alleles at both the
Vra1 and Vra2 positions (Fig 3D), which further supports the
existence of an additive effect between these two loci. The effect
plots of the markers displaying the maximum LOD score for Vra1
and Vra2 are shown in Fig 3E and 3F, respectively. Animals
Figure 2. Genetic linkage to neurodegeneration for the Vra1 region. (A) LOD score plot for linkage to Vra1 in the individual G8 and G10
cohorts, and meta-analysis calculated by marker regression for the combined dataset. (B) Survival of motoneurons in the combined population
stratified for genotype at the max marker of Vra1 (D8Rat205), demonstrating reduced survival in rats homozygous for the DA allele. Lines indicate the
mean with error bars at +/2 1 SE. (C) Comparison of the original LOD score plot obtained in the F2 population and the current obtained in the AIL.
doi:10.1371/journal.pone.0005906.g002
Table 1. Summary of max and flanking microsatellite markers, and LOD scores for the different linkage peaks obtained in G8, G10
and the combined cross analysis, respectively.
Method G8 G10 Combined
G8 G10 G8+G10
Imputation Imputation
Marker
regression
Marker
regression
Marker
regression
QTL VRA1 VRA2 VRA1 VRA2 VRA1/VRA2ADDITIVE VRA1 VRA1 VRA1
Peak marker(s)
(Position, Mb)
D8Rat138 (89.06) N/A D8Mgh4 (86.63) D5Rat190 (24.98) D5Rat190/D8Rat75
(24.98,89.56)
D8Rat138 (89.06) D8Rat205 (86.29) D8Rat205 (86.29)
LOD score 3.46 N/A 3.19 2.39 6.39 2.77 3.45 5.87
1.8 LOD drop interval
(Position, Mb)
D8Rat26-D8Rat14
(79.35–104.7)
N/A D8Rat26-D8Rat14
(79.35–104.7)
D5Rat209-D5Rat6
(23.24–52.53)
N/A D8Rat185-
D8Rat14 (64.57–
104.7)
D8Rat26-D8Rat14
(79.35–104.7)
D8Rat24-D8Rat129
(82.25–98.95)
99% Bayesian credible
interval (Position, Mb)
D8Rat38-D8Rat14
(54.63–104.7)
N/A D8Rat26-D8Rat14
(79.35–104.7)
D5Rat209-D5Rat6
(23.24–52.53)
N/A D8Rat185-
D8Rat129 (64.57–
98.95)
D8Rat24-
D8Rat129 (82.25–
98.95)
D8Got128-
D8Rat129 (85.83–
98.95)
doi:10.1371/journal.pone.0005906.t001
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PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5906Figure 3. Genetic linkage to neurodegeneration for the Vra2 region on chromosome 5. (A) LOD score plot for linkage to Vra2 in the G10
cohort. Survival of motoneurons in the G10 (B) population stratified for genotype at the max marker of Vra2 (D5Rat190), demonstrating reduced
survival in rats homozygous for the DA allele. Lines indicate the mean with error bars at +/2 1 SE. (C) Comparison of the original LOD score plot
obtained in the F2 population with the current obtained in the AIL. (D) An interaction plot shows an additive effect in terms of increased nerve cell
loss in carriers of DA alleles both at the Vra1 and Vra2 positions and the lowest nerve cell loss for individuals being PVG
av1 homozygous at both loci.
Animals homozygous at both positions have similar survival ratios as the corresponding parental controls. Effect plot of markers giving max additive
LOD for Vra2 (E) and Vra1 (F) in the G10 cohort.
doi:10.1371/journal.pone.0005906.g003
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mean nerve cell survival as compared to 49% mean survival in
animals homozygous for PVG
av1 alleles at both markers. This can
be compared to the mean values of 38% and 47% for parental DA
and PVG
av1 strains, respectively. This suggests that the additive
effect of Vra1 and Vra2 accounts for a large part of the difference
observed between the two parental strains.
DA.PVG-Vra1 congenic rat strains
The in vivo effect of Vra1 was examined in three separate
congenic strains that contain overlapping fragments of the Vra1
region from the PVG
av1 genome on DA background: DA.PVG
av1-
Vra1-R1 (R1), DA.PVG
av1-Vra1-R2 (R2) and DA.PVG
av1-Vra1-
R3 (R3). In a first experiment, survival of motoneurons 21 days
after VRA in congenic animals was compared to parental DA
controls, showing a significantly increased survival of axotomized
cells in R1 (p,0.05), but not R2 animals. The experiment was
repeated with the R3 strain included. Again, motoneuron survival
in the R1 strain was significantly higher 21 days after VRA
compared to DA parental controls (p,0.05). The R3 strain also
displayed a significant reduction of nerve cell loss compared to the
DA strain (p,0.01). As intra-strain differences in mean survival
ratios and standard deviations are very small between the two
experiments, results are presented as pooled data (Fig 4). Pooling
the data resulted in an even more significant effect of the R1
fragment, with a mean nerve cell survival of 28% in the congenic
strain representing a 48% increase compared to the parental strain
control (DA; p,0.001). Motoneuron survival in R3 was identical
to the R1 strain (28%; p,0.01 compared to DA). R2 did not differ
from control DA animals (22% and 19%, respectively).
The mean nerve cell survival at 21 days was 19% in parental
DA rats as compared to 38% in parental PVG
av1 rats (p,0.001).
In the AIL experiment, the difference between the parental strains
was less pronounced, which is explained by the later time-point
used for determining motoneuron survival in the congenic study.
The outcome of the experiment strongly suggests that the
causative genetic variation of Vra1 is located within the common
genomic region of the R1 and R3 strains, but outside of the R2
fragment, i.e. a 9 Mb genomic interval between the markers
D8Rat24 and D8Got145. A schematic map of the congenic
fragments’ location on chromosome 8, including the genes in the
interval, is depicted in Figure 5.
Comparative genomics revealed 12 QTLs in the synthenic
mouse region (chr 9 approx 78–90 Mb), none of which were
linked to neurodegenerative disorders (data not shown). However,
this probably reflects the fact that few, if any, studies attempting to
map QTLs for phenotypes related to neurodegeneration have
been published. Further, 42 human homologues for the rat genes
in the R3 fragment were found,of which most are located on
chromosome 6. Mutations in a number of the human genes cause
various Mendelian disorders, but only one of them shows
association to complex disease in Genatlas (www.genatlas.org).
Human homologues with associated diseases are presented in
Supporting Table S1.
Discussion
We here demonstrate a considerable variability in susceptibility
to nerve injury-induced neurodegeneration that can be attributed
to naturally occurring genetic differences between the inbred DA
and PVG
av1 strains.
Loss of nerve cells is a characteristic feature of many CNS
diseases. It may be secondary to traumatic injuries or inflamma-
tory diseases such as multiple sclerosis (MS), or occur as a primary
disease process, as is the case in amyotrophic lateral sclerosis (ALS)
and Parkinson’s disease. The common forms of these diseases
often have a complex etiology, which includes a genetic
component [12]. Knowledge about disease predisposing genes is
of importance for disclosing pathogenic pathways that could be
targeted therapeutically. However, unlike monogenic diseases,
genes involved in complex traits often only modestly affect disease
and are therefore more difficult to identify. So far, very few studies
have examined the genetic impact on neurodegenerative processes
using an unbiased experimental approach [13,14,15].
The two regions examined here, Vra1 and Vra2, are the first
nerve cell death regulating QTLs to be characterized and fine
mapped using an advanced intercross line. These findings suggest
that genetic variability in this key feature of the axon reaction is
controlled by a low number of gene loci containing genes that are
polymorphic between the examined strains. We report indepen-
dent observations of significant effects of Vra1 on the degree of
neurodegeneration in genetically heterogenous intercrossed ani-
mals as well as in congenic strains, where only the Vra1 locus has
been exchanged between the two parental strains. This lends
strong support for functional biological effects originating from
genetic elements within the Vra1 locus. In the preceding F2 scan,
the approximate physical genomic size of Vra1 locus was 55 Mb.
The confidence interval of the combined AIL cohorts now reduce
the size to approximately 16 Mb. In addition, the congenic
experiment provides further reduction of the candidate interval to
just over 9 Mb. Preserved phenotypic effect of a QTL in a
congenic strain is the ultimate proof of linkage. In this context, the
Vra1 region is unique in showing replicated significant effects on
motoneuron survival after nerve injury.
In the F2 scan, Vra2 displayed suggestive linkage to neuronal
loss after VRA. In this study, we reproduce suggestive linkage of
Figure 4. Survival of motoneurons 21 days after VRA in
congenic rats containing overlapping genomic fragments of
the Vra1 region. The results are presented as pooled data from two
independent experiments, which yielded highly similar results. Moto-
neuron survival in R1 and R3 animals is significantly increased
compared to DA controls, whereas R2 animals retain the DA phenotype.
PVG
av1 parental animals are also included as a measure of the parental
strain differences. Lines indicate the median. (**p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0005906.g004
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Nevertheless, in the G10 cohort both Vra1 and Vra2 show
independent linkage as well as a highly significant contribution to
the combined linkage, which supports a biological effect of Vra2.
Furthermore, individuals which are homozygous at both loci for
either of the parental genotypes almost exactly resemble the
Figure 5. View of chromosome 8 with congenic fragments of DA.PVGav1-Vra1-R1, -R2 and -R3 strains indicated on the left and the
1.8 LOD drop interval for G8+G10 combined QTL analysis marked in red. The 45 protein coding genes located in the shared congenic
fragments of R1 and R3animals are listed on the right. Dashed lines indicate regions between microsatellite markerswhere the recombination has
occurred, thereby being genes possibly included in the fragment. Information about genes is based on Rat Genome V3.4 Assembly.
doi:10.1371/journal.pone.0005906.g005
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taken together thus account for a major part of the difference
between the two parental strains.
After nerve avulsion, neurodegeneration is initiated around 7
days after injury and reaches a plateau at day 21 [8]. The AIL
populations were sampled 14 days after injury, to comply with
analyses of other aspects of the VRA response, whereas the
congenic animals were sampled at day 21. Thus, the QTLs
detected in the intercross lines are mapped at a timepoint when
only half of the degeneration has occurred, which may reduce
power to detect the relatively weaker linkage to Vra2. Studies in
animals congenic for Vra2 at 21 days after injury will likely increase
the possibility to capture the effect of this locus as the segregation
between parental strains with regard to neurodegeneration
increases with time after injury. Congenic strains are now being
bred in our laboratory, to allow for functional verification of Vra2.
The Vra1 candidate region of 9 Mb contains 59 genes in the rat
of which 45 are protein coding and 14 pseudo genes, which is too
large a number to pinpoint candidate genes. However, the list
contains a number of genes that are of importance for cell cycle
regulation, a process which recently has been implicated in
neurodegeneration (see eg.[16,17,18]), and genes encoding
reducing agents regulating oxidative stress, which is implicated
in neurodegenerative disorders such as Alzheimer’s disease,
Parkinson’s disease and ALS [19,20,21].
However, comparative genomics revealed no known association
of the human homologues of the Vra1 genes to any human
complex disease, underscoring the need for further investigation of
this region.
In conclusion, we here genetically characterize the first two
regions that regulate axotomy-induced nerve cell deaths and
provide a comprehensive list of candidate genes in the Vra1
interval. Most importantly, we provide experimental, biological
evidence from Vra1 congenic rat strains that Vra1 regulates the
degree of motoneuron degeneration after nerve injury. We also
give further support to the suggestive QTL Vra2 and show a
significant additive effect of these two loci. Further studies are
ongoing to exactly define the underlying genetic variation
underlying Vra1, primarily using recombinant breeding of existing
congenic strains. Positional identification of responsible genes and
the use of comparative genomics will be of importance for the
understanding of the genetic regulation of susceptibility to
neurodegeneration and may increase our understanding of
conditions such as brain and spinal cord trauma, MS, cerebro-
vascular and neurodegenerative diseases.
Materials and Methods
Animals and breeding
The DA (RT1AV1) strain was originally generously provided by
Professor Hans Hedrich (Medizinische Hochschule, Hannover,
Germany), while the PVG-RT1AV1 (hereafter called PVG
av1)
strain was obtained from Harlan UK Ltd (Blackthorn, UK). These
two rat strains carry the same MHC haplotype and any
phenotypic differences in crosses between them will originate
from non-MHC genes. Animals used for experiments were bred in
our in-house breeding facility under specific pathogen-free and
climate-controlled conditions with 12 h light/dark cycles, housed
in polystyrene cages containing wood shavings, and fed standard
rodent chow and water ad libitum. The AIL was created by
reciprocal breeding of DA and PVG
av1 rats. Subsequent crossings
of offspring from 50 breeding pairs were carried out for eight (G8)
or ten (G10) generations, respectively. In a previous F2 scan
parental animals displayed a 36% relative increase in survival of
motoneurons 14 days following VRA in PVG rats compared to
DA [11]. Although mean survival rates of motoneurons did not
differ between males and females, the variability obtained in the
F2 cohort tended to be greater in females and linkage to Vra1 and
Vra2 was weaker. Therefore, only males were studied in the
experiments presented here. VRA experiments were performed in
two AIL populations, G8 and G10. In the G8 generation, 12 rats
from each parental strain and 126 male rats were used and in the
G10 generation, 12 DA rats and 11 PVG
av1 parental rats and 186
male rats.
The congenics were bred by selecting male PVG
av1 allele
donors from the G8 AIL cohort, in order to transfer relatively
short and well defined overlapping genome fragments of the Vra1
region. The congenic intervals are defined by the following
excluding markers, DA.PVG
av1-Vra1-R1 (RNO8: D8Rat146-
D8Got145, [73.1–91.3 Mb]); DA.PVG
av1-Vra1-R2 (RNO8:
D8Rat41-D8Rat24 [50.4–82.2 Mb]). Repeated backcrossing to
the recipient DA strain was performed for an additional nine
generations to create congenics with theoretically ,0.1% of the
donor genome outside the Vra1 locus. The DA.PVG
av1-Vra1-R3
(RNO8: D8Rat24-D8Got145 [82.2–91.3 Mb]) is a recombinant
from the DA.PVG
av1-Vra1-R1 congenic and was bred separately
after a recombination event in the 4
th generation of backcrossing
to DA. Experiments on congenic rats were performed with 9–10
animals in each group.
Nerve lesion
All animals were subjected to unilateral avulsion of the left L3-
L5 ventral roots under standardized conditions and in deep
isoflurane anesthesia at an age of 6–8 (G8) or 8–10 (G10 and
congenics) weeks with a post-operative survival time of 14 (G8 and
G10) or 21 (congenics) days (+/2 2 hrs), after which animals were
killed with CO2 and perfused with cold PBS. The shorter post-
operative survival time in the AIL cohorts was chosen to comply
with the survival time used in the original F2 genome-wide scan
[11]. Data on genetic differences in VRA-induced expression of
MHC class II in the G8 and a subset of animals from the G10
cohort has been presented previously [5]. In the congenics
experiment a three weeks post-operative survival was chosen,
since parental strains differ more with regard to nerve cell survival
at this time point [8]. After dissection the spinal cords were
carefully examined in a dissection microscope to verify the
completeness of the lesion. In no case did the microscopic
examination reveal signs of hemorrhage, necrotic zones or direct
damage to the cord. Animals with incomplete lesions were
excluded from further analysis. All experiments in this study were
approved by the local ethical committee for animal experimen-
tation (Stockholms Norra Djurfo ¨rso ¨ksetiska Na ¨mnd) and comply
with the guidelines from the Swedish National Board for
Laboratory Animals and the European Community Council
Directive (86/609/EEC).
Cell counts
Serial transverse frozen sections (14 mm) of tissue from the L4
segment of the spinal cord were cut with a cryostat. Nerve cell
counts of cresyl violet counterstained sections were performed as
described previously [9,11]. In brief, counts of motoneurons with a
visible nucleus were performed blindly by a single observer on
every fifth section with a total of 20 sections from each rat, in total
covering a distance of approximately 2 mm in the rostro-caudal
axis. Each slide contained sections from 9 rats mounted in a
similar fashion in order to reduce the risk of bias. Parental rats
were randomly included as a measure of inter-individual
consistency. G8, G10 and congenic rat cohorts were counted by
Vra1/Vra2 Regulate Neuron Loss
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reduction in mean soma size of axotomized cells as compared to
unlesioned cells on the contralateral side was highly similar (227–
28%) regardless of sex or strain [11]. No correction for cell
shrinkage was performed here as this feature is expected to affect
the studied cell populations to a similar degree. The degree of
neurodegeneration is presented as a ratio of the total number of
motoneurons on lesioned and unlesioned sides, respectively, in
each rat. Micrographs were recorded on a Zeiss Axioskop
microscope system.
Genotyping
Genomic DNA was extracted from tail tips or ear clippings
using a standard protocol. PCR-primers for polymorphic simple
sequence length polymorphisms (SSLPs) were selected from
available internet databases (Rat Genome Database
(rgd.mcw.edu), Center for Genomic Research, Whitehead Insti-
tute/MIT (www-genome.wi.mit.edu/rat/public), Ensembl (www.
ensembl.org) and UniSTS at NCBI (www.ncbi.nlm.nih.gov). The
primers were purchased from PROLIGO (Paris, France). One
primer in each pair was labeled with [c-
33P]ATP (PerkinElmer,
Boston, MA), genomic DNA was amplified with a standard PCR
protocol, and the amplified fragments were separated on 6%
polyacrylamide gels (National Diagnostics, Atlanta, GA). Geno-
types were recorded manually from autoradiographic films
(Biomax, Kodak, Rochester, NY) independently by two investiga-
tors. DNA from DA and PVG
av1 rats were included for each
marker.
Linkage analysis and statistics
Linkage analysis was performed using GNU R 2.6.0 with the
QTL package version 1.07–12 (R/qtl) [22]. Analysis was
performed for the G8 and G10 generations separately but also
in a combined analysis to increase statistical power. Separate
analyses were performed with the multiple imputation method
(normal model) with 64 simulations (step=2, ndraws=64) in R/
qtl. Because different generations were combined in the combined
cross analysis, marker regression with 64 simulations was used.
Only physical positions for the markers were used in the combined
analysis since they, in contrast to genetic positions, are constant
between generations. Experiment-wise significance threshold levels
were generated by the permutation method in R/qtl using 10 000
permutations [23]. Furthermore, family residuals were calculated
to rule out that peaks are derived from family effects. This was
done by subtracting the average litter phenotype score from that of
each individual sibling in that litter, and running the same
imputation analysis as above on the data obtained. The highest
LOD score from this analysis was used as the threshold level for
family effect. Confidence intervals for the peaks were determined
by using 1.8 LOD support intervals and 99% Bayesian credible
intervals [24]. A two-dimensional scan was performed for
interactions and additive influences. A multiple qtl model was
fitted dropping the effect of one of the QTLs at a time to
determine interaction and significance for each of the QTLs on
the full model. LOD-plots and effect/interaction-plots were
generated with R/qtl.
Significance levels for phenotypic differences between the
parental and congenic strains were calculated with non-parametric
ANOVA, with Dunn’s Multiple Comparisons Test, using
GraphPad Prism 3.0 (GraphPad Software Inc, San Diego, CA).
Comparative genomics was used to check the smallest congenic
fragment for synthenic human and mouse regions with Ensembl
release 53. All human homologue genes were checked in Genatlas
(release Tue 30 Dec 2008), and the mouse synthenic region was
checked in the MGI_4.2 database, for association and/or linkage
to disease.
Supporting Information
Table S1 Human genes, homologous with genes in smallest
congenic fragment on rat chromosome 8. Diseases associated with
the human genes are given in the right column. List of human
homologues to the rat genes located within the R3 congenic
fragment. No association of any human gene to complex
neurodegenerative disease.
Found at: doi:10.1371/journal.pone.0005906.s001 (0.11 MB
DOC)
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